Intellectual Property

  • April 15, 2026

    Fla. Judge Told Ex-CEO Drove Energy Drinks Co. Into Ch. 11

    A liquidating trust Wednesday urged a Florida federal bankruptcy judge to hold the former CEO of the company that makes Bang Energy drinks liable for breaching fiduciary duty, arguing that a multimillion-dollar judgment stemming from his violation of a trademark settlement partially contributed to the business' Chapter 11.

  • April 15, 2026

    Judge Doubts C4, Bloom Ex-Execs Should Lose New Jobs

    A Texas federal judge was skeptical Wednesday of approving injunctive relief that would bar executives from working at a relaxation beverage company months after leaving the maker of C4 and Bloom energy drinks.

  • April 15, 2026

    $7M Grubhub TM Deal Receives Ill. Judge's Final OK

    An Illinois federal judge gave her final blessing Wednesday to a $7.1 million settlement between Grubhub and more than 7,000 restaurants that say the food delivery service used their trademarks without permission to gain a competitive edge over DoorDash and Uber Eats.

  • April 15, 2026

    Fed. Circ. OKs Denial Of Most Claims In Golf Club Patent App

    The Federal Circuit said Wednesday it won't revive claims from a patent application for a golf club head by Cobra Golf, backing findings from federal patent officials that several claims in the application were obvious.

  • April 15, 2026

    Squires Passes On 10 Patent Challenges, Takes On 2 Others

    The newest bulk order from U.S. Patent and Trademark Office Director John Squires has rejected 10 petitions for America Invents Act patent reviews while granting a couple others, including a Google challenge to a patent owned by Headwater Research LLC.

  • April 15, 2026

    Head Shaver Co. Seeks Toss Of Rival's Patent Suit

    A company that makes head shavers asked a North Carolina federal judge Wednesday to throw out a case alleging that it infringed one patent and one design patent held by a rival, saying the suit has no chance of plausibly showing that its products are infringing.

  • April 15, 2026

    Fertility Biz Progyny Hit With TM Suit In Pennsylvania

    Fertility benefit management company Progyny Inc.'s expansion into pregnancy and postpartum care while using the "Progyny" trademark will create confusion in the marketplace by overlapping with similar but differently spelled marks, a new lawsuit from ProgenyHealth LLC claims.

  • April 15, 2026

    USPTO Eying Older Patent Apps, Busier Tech For New Pilot

    A U.S. Patent and Trademark Office leader on Wednesday clarified when the agency plans to flag patent applications that have already gone through the Patent Cooperation Treaty international review process, in a pilot program to cut down on the examination backlog. 

  • April 15, 2026

    Judge Limits Evidence In Revived Deloitte Trade Secret Case

    A West Virginia federal judge has narrowed the evidence prosecutors can present at trial in a revived trade secret case against two former Deloitte employees, curtailing use of an internal investigative report from the company they joined and restricting how "trade secrets" may be used to describe allegedly confidential materials.

  • April 15, 2026

    NC Judge Won't Undo $4M Philips Copyright Verdict

    A North Carolina federal judge has refused to erase a $4 million jury verdict against independent service organization Transtate Equipment Co. for violations of the Digital Millennium Copyright Act, saying trial evidence provided a "firm basis" to support the jury's statutory damages award.

  • April 15, 2026

    Fed. Circ. Won't Touch DraftKings Win In PTAB Fight

    In a one-word decision Wednesday, the U.S. Court of Appeals for the Federal Circuit upheld a Patent Trial and Appeal Board decision that found a peer-to-peer gaming patent challenged by DraftKings was not valid.

  • April 15, 2026

    Willkie Adds O'Melveny Litigator To Los Angeles Office

    Willkie Farr & Gallagher LLP expanded its Los Angeles office with the recent addition of a litigator who moved her practice after nearly 15 years with O'Melveny & Myers LLP.

  • April 15, 2026

    Biopharma Co. Says Ex-Worker Used Files To Build AI Rival

    A biopharmaceutical consulting firm's ex-contractor illegally downloaded thousands of proprietary internal files and emails that he then used to launch a rival company powered by artificial intelligence, the firm claimed in a lawsuit, alleging that the former contractor violated federal trade secrets law.

  • April 15, 2026

    Re-Uz Sues Rival Over 'Eco Cup' Marks, Client Data

    A group of companies specializing in sustainable cups has sued a competitor, accusing it of infringing its marks in branding for its reusable cups and misusing its trade secrets to poach clients.

  • April 14, 2026

    2nd Circ. Mulls Bid To Save Walmart, E-Commerce Co. IP Case

    A Second Circuit panel on Tuesday grappled with a group of businesses' attempt to revive its copyright and trademark case against Walmart and an e-commerce company, with the judges wondering whether the businesses impermissibly expanded their safe harbor arguments on appeal.

  • April 14, 2026

    VLSI's Calif. IP Suit Against Intel Revived By Fed. Circ.

    The Federal Circuit breathed new life into one of VLSI Technology's patent infringement suits against Intel Corp. on Tuesday, concluding a California federal judge wrongly interpreted an agreement between the companies to limit the scope of litigation.

  • April 14, 2026

    Amazon Suit Alleges $4M Fraud By 'Refund Abuse' Ring

    Amazon launched a lawsuit Tuesday targeting architects of what the retail giant claimed is an international fraud ring known as RBK that allegedly cheated the company out of $4 million in products through a "refund abuse" scam that allows users to obtain refunds despite keeping the goods.

  • April 14, 2026

    USPTO Rejects Nike's Trademark Bid For Bronny James' Logo

    The U.S. Patent and Trademark Office has shot down Nike's attempt to register a trademark on the logo used by LeBron James' son and Los Angeles Lakers player Bronny James, although it gave the company a chance to respond to the refusal.

  • April 14, 2026

    Wash. Appeals Court Revives Podiatrist Trade Secrets Case

    An appeals court in Washington state has reinstated a case brought by a Seattle-area podiatry practice against a former employee accused of stealing patient data for his separate practice.

  • April 14, 2026

    Fed. Circ. Affirms On-Sale Bar Ax Of Car Software Patent

    The Federal Circuit on Tuesday upheld a decision invalidating a patent on modifying vehicle engine software because the invention was on sale before the patent was sought, siding with auto equipment maker Powerteq LLC and rejecting an argument that the ruling was based on hearsay.

  • April 14, 2026

    3rd Circ. Upholds J&J Injunction Bid Loss In Biosimilar Fight

    The Third Circuit on Tuesday ruled that a Johnson & Johnson subsidiary couldn't justify its bid for an order blocking Samsung Bioepis from paving the way for a Cigna unit to launch a generic version of an anti-inflammatory treatment.

  • April 14, 2026

    3 Firms Guide TPG's Bet On College Sports Rights Giant

    Alternative asset manager TPG said Tuesday it has agreed to acquire Learfield, a leading college sports media and technology company, in a deal steered by three law firms. 

  • April 14, 2026

    Mintz Can't Halt Texas Malpractice Suit For Fee Fight In Mass.

    A Massachusetts federal judge on Tuesday declined Mintz Levin Cohn Ferris Glovsky and Popeo PC's request to halt a former client's legal malpractice case against the firm in Texas federal court while the two fight over a $2 million "success fee" the law firm claims it is owed.

  • April 14, 2026

    Alleged Bootleggers Of Springsteen Merch Hit With Injunction

    A New Jersey federal judge has granted concert merchandise company Merch Traffic LLC a preliminary injunction and seizure order authorizing law enforcement officers to confiscate allegedly counterfeit Bruce Springsteen merchandise ahead of upcoming performances, including an April 20 show in the Prudential Center in Newark.

  • April 14, 2026

    Rakoff Says $300M Piracy Case Among Worst He's Seen

    U.S. District Judge Jed S. Rakoff entered default judgment Tuesday at the request of a group of music companies against the online shadow library Anna's Archive, calling the piracy instigated by the site one of the most "horrendous acts of piracy brought to my attention."

Expert Analysis

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

    Author Photo

    With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

  • How 2 Tech Statutes Are Being Applied To Agentic AI

    Author Photo

    The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.

  • FTC Focus: Testing Joint Enforcement Over Loyalty Programs

    Author Photo

    The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.

  • NYC Bar Opinion Warns Attys On Use Of AI Recording Tools

    Author Photo

    Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Checking In On Biologics-Related Patent Review Trends

    Author Photo

    Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Patent Eligibility Faces Widening Gap Between USPTO, Courts

    Author Photo

    The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.

  • Series

    Playing Tennis Makes Me A Better Lawyer

    Author Photo

    An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.

  • Expect Major Shifts In Patent And Trademark Policy This Year

    Author Photo

    New leadership and initiatives promise to bring consequential changes to the U.S. Patent and Trademark Office's practices in 2026, likely favoring patent allowance and issuance, as well as streamlining trademark processes, say attorneys at Knobbe Martens.

  • And Now A Word From The Panel: MDL Year In Review

    Author Photo

    2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.